Product information
Product Overview
CagriSema 10mg is a pre-blended lyophilised research material containing 5mg Cagrilintide and 5mg Semaglutide in a single vial, supplied for in-vitro laboratory and analytical use only. Products selected for website presentation meet Solatide Biosciences' ≥99% purity standard based on available third-party documentation.
GLP-1 & Metabolic Peptides | GLP-1 Research Overview | Cagrilintide & Semaglutide: Dual-Receptor Synergies
Technical Specifications
| Property | Value |
|---|---|
| Purity | ≥99% |
| Composition | 5mg Cagrilintide + 5mg Semaglutide |
| Total Content | 10mg per vial |
| Form | Lyophilised Blend |
| Cagrilintide CAS | 2173274-03-6 |
| Semaglutide CAS | 910463-68-2 |
| Appearance | White Lyophilised Powder |
Research Applications
- Dual GLP-1 and amylin receptor pathway studies in vitro
- Receptor crosstalk and synergistic signalling investigations
- In vitro receptor binding assays for combined incretin and amylin activity
- Comparative single-agent vs combination-model research designs
- Metabolic signalling pathway analysis in experimental cell models
For in-vitro laboratory research use only.